Delivery Order SPE2DB24D2013-SPE2DB25FCKDC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Nexium DR 40 mg capsules (30-count units) with a ceiling value of $2,323.45. This firm fixed price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was made through competitive procurement with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,804.10 on July 22, 2025, for the supply of Nexium DR 20 mg capsules (30-count packages). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.50 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsules (30-count units). The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a contract ceiling value of $2,250.08 and a firm fixed price structure. This non-set-aside competitive award is scheduled for completion by August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $17,748.41 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Nexium DR 20 mg capsules on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was awarded without set-aside provisions through open competition, reflecting the vendor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 12, 2025. The order, valued at $2,064.24 with a firm fixed price structure, is for 90-count bottles of Nexium DR 40 mg capsules. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for NEXIUM DR 20 mg capsules (90-count) valued at $1,299.08 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the...
- The Defense Logistics Agency (DLA) awarded a $2,351.58 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This firm fixed-price contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a direct delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The contract utilizes no set-aside designation and was awarded competitively. Performance will occur at the contractor's...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKDCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering brand-name and generic medications across multiple therapeutic domains. The company's capability to meet federal requirements through open competition is demonstrated by its consistent receipt of non-set-aside, competitively awarded contracts ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/8/25 |